Injective has launched the Injective Policy Institute (IPI) to work directly with US lawmakers on creating clear regulatory frameworks for decentralized finance (DeFi), stablecoins, tokenized assets, and onchain derivatives. Led by John Medel, the IPI aims to position the US as a leader in digital asset innovation by promoting clarity, access, sovereignty, and American leadership in onchain finance. This move is crucial as regulatory decisions could either restrict or boost institutional adoption of Injective's core financial products. The IPI plans to provide technical briefings and policy analyses to influence upcoming regulations, especially in stablecoins and tokenization sectors where major regulatory actions are expected soon.
Injective (INJ) held its $4.5 support level and rebounded to $5.4 before settling around $5. The rebound was driven by increased speculative trading, with open interest and derivatives volume surging, especially on Binance and OKX where long position...
MemeCore surged 9.45% to $3.47, leading gains among the top 100 cryptocurrencies by market cap, followed by NEAR Protocol, Ondo, Injective, and edgeX with increases between 6.3% and 7.6%. This reflects a rotation into higher-risk, high-beta tokens as...
KITE led Upbit's crypto greed index with a score of 76 despite a 5.04% price drop to 339 won, signaling a cooling phase rather than a trend reversal. The token saw heavy trading volume (~15.06 billion won), indicating active repositioning amid sustai...
Crypto markets experienced a volatile week driven by macroeconomic factors, with Bitcoin briefly surpassing $80k before retreating amid inflation and risk concerns. Infrastructure token Kite (KITE), social crypto Humanity (H), and DeFi protocol Injec...
